HEXO has submitted a voluntary delisting application to the Toronto Stock Exchange and the Nasdaq Stock Market and, as a result of the Arrangement, the Company expects its Common Shares to be delisted from the TSX and the Nasdaq shortly.
Save time and jump to the most important pieces.
| Company | Date | Price Target | Rating | Analyst |
|---|---|---|---|---|
| 4/5/2024 | $2.25 → $2.75 | Neutral | Alliance Global Partners | |
| 11/2/2022 | $3.90 | Mkt Perform | Bernstein | |
| 7/29/2022 | $3.00 | Hold → Sell | The Benchmark Company | |
| 3/4/2022 | $1.00 → $1.25 | Hold → Speculative Buy | Canaccord Genuity | |
| 3/4/2022 | Hold → Speculative Buy | Canaccord Genuity | ||
| 3/4/2022 | $1.20 → $0.90 | Neutral | Cantor Fitzgerald | |
| 3/4/2022 | $9.00 | Hold → Buy | Canaccord Genuity | |
| 1/27/2022 | $1.07 → $0.53 | Underperform → Hold | Jefferies |
Tilray Achieves 13% Year-Over-Year Growth, Generating Record Q1 Net Revenue of $200 Million Q1 Gross Margin Increases Over 500 Basis Points, Representing 20% Year-Over-Year Growth Tilray Beverages Achieves 132% Net Revenue Growth, Tilray Alternative Beverages Launched in October to Fuel Key U.S. Markets with Hemp-Derived Delta-9 THC Products German Medical Cannabis Flower Revenue Increases by 50% Following Legalization Conference Call to be Held at 8:30 a.m. ET Today NEW YORK and LEAMINGTON, Ontario, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray", "our", "we" or the "Company") (NASDAQ:TLRY, TSX:TLRY), a leading global lifestyle and consumer packaged goods company, tod
NEW YORK and LEAMINGTON, Ontario, Sept. 30, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or the "Company") (NASDAQ:TLRY, TSX:TLRY), a leading global lifestyle and consumer packaged goods company, today announced that the Company will release its financial results for the first quarter which ended August 31, 2024 before the financial market opens on October 10, 2024. Live Conference Call and Audio Webcast Tilray will host a live conference call, which will be webcast, to discuss these results at 8:30 am Eastern Time. The webcast can be accessed on the Investors section of Tilray's website at www.Tilray.com. Investor Q&A Tilray Brands stockholders can submit and upvote question
Achieved Net Revenue of $188 Million, ~ 30% Net Revenue Growth Over the Prior Year Quarter Beverage-Alcohol Net Revenue Increases 165% Over the Prior Year Quarter, 5th Largest Craft Beer Brewer in the U.S.1 with 4.5% Craft Beer Market Share Global Cannabis Net Revenue Increases 33% with International Cannabis Growth of 44% Over the Prior Year Quarter, #1 Market Share in Canada and #1 Market Share in Germany U.S. Cannabis Strategy in Place to Strike with Potential Drug Policy Reform Conference Call to be Held at 8:30 a.m. ET Today NEW YORK and LEAMINGTON, Ontario, April 09, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray", "our", "we" or the "Company") (NASDAQ:TLRY, TSX:TLRY), a
8-K - Tilray Brands, Inc. (0001731348) (Filer)
DEFA14A - Tilray Brands, Inc. (0001731348) (Filer)
8-K - Tilray Brands, Inc. (0001731348) (Filer)
GAINERS: Global Hemp Group (OTC:GBHPF) shares closed up 117.39% at $0.04 CordovaCann (OTC:LVRLF) shares closed up 19.90% at $0.06 SOL Glb Inv (OTC:SOLCF) shares closed up 19.40% at $0.06 1933 Industries (OTC:TGIFF) shares closed up 11.81% at $0.01 Global Compliance (OTC:FUAPF) shares closed up 10.37% at $0.00 CLS Holdings USA (OTC:CLSH) shares closed up 6.01% at $0.04 22nd Century Group (NASDAQ:XXII) shares closed up 4.77% at $0.72 EnWave (OTC:NWVCF) shares closed up 4.53% at $0.17 Psychemedics (NASDAQ:PMD) shares closed up 3.52% at $2.24 cbdMD (AMEX:YCBD) shares closed up 3.11% at $0.63 LOSERS: Green Growth Brands (OTC:GGBXF) shares closed down 99.00% at $1e-06 Leafbuyer Techs (OTC:LBUY)
Cannabis giant Tilray Brands, Inc. (NASDAQ:TLRY) announced Wednesday it has obtained second approval for a new medical marijuana extract in Portugal. The medical cannabis extract that got this approval is Tilray Oral Solution THC10:CBD10. This milestone follows up on the successful approval of Tilray Medical's whole flower THC 18, and approval for the first cannabis extract in Portugal earlier this year. Tilray has been working on its European presence extensively this year. This week the company confirmed its German cannabis cultivation facility, Aphria RX GmbH, has obtained the first new cannabis cultivation license issued under MedCanG, Germany’s new Cannabis Act. Read Also: 90% Of
SC 13G/A - Tilray Brands, Inc. (0001731348) (Subject)
SC 13G - Tilray Brands, Inc. (0001731348) (Subject)
SC 13G/A - HEXO Corp. (0001690947) (Subject)
Alliance Global Partners reiterated coverage of Tilray with a rating of Neutral and set a new price target of $2.75 from $2.25 previously
Bernstein initiated coverage of Tilray with a rating of Mkt Perform and set a new price target of $3.90
The Benchmark Company downgraded Tilray from Hold to Sell and set a new price target of $3.00
4 - Tilray Brands, Inc. (0001731348) (Issuer)
4 - Tilray Brands, Inc. (0001731348) (Issuer)
4 - Tilray Brands, Inc. (0001731348) (Issuer)
PATCHOGUE, N.Y., Oct. 22, 2024 (GLOBE NEWSWIRE) -- Blue Point Brewing Company, Long Island's original craft brewery and subsidiary of Tilray Brands, (NASDAQ:TLRY, TSX:TLRY), is proud to announce the continuation of its men's health awareness campaign in support of Movember. The month shines a light on key men's health issues—mental health, prostate cancer, and testicular cancer—encouraging open conversations and proactive engagement. To honor the initiative, Blue Point Brewing announced the special release of its classic double IPA, Big Mo, available at our brewery and retailers in Long Island, New York. This hazy double IPA, featuring prominent mosaic hops and an ABV of 8.0%, proud
FORT COLLINS, Colo., Aug. 05, 2024 (GLOBE NEWSWIRE) -- Breckenridge Brewery, a Colorado-based craft brewer with over 30 years of experience brewing approachable, well-balanced beers, announces the opening of its new brewery location in Fort Collins. With doors opening in early August 2024, the new 10,000-square-foot Breckenridge Brewery offers a full restaurant experience and a new vibrant atmosphere in the heart of Fort Collins for all to enjoy. The new location will be a full-service restaurant, upholding the Breckenridge Brewery legacy while ushering in new opportunities for innovation and community collaboration. With a menu boasting a diverse range of culinary delights designed to co
TORONTO, May 30, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (NASDAQ:TLRY, TSX:TLRY), a leading global lifestyle and consumer packaged goods company, today announced the highly anticipated Good Supply® ‘Twisted' All-In-One ("AIO") Vapes hitting the market, offering a revolutionary way to experience its delicious vape flavours. With the ability to switch between complimentary flavours or combining them for a "twist" – creating a unique third flavour experience of the two flavours enjoyed together, Good Supply has a jam packed vape with a series of unique flavour possibilities all-in-one, ready to go for consumers looking for variety that packs a punch. With the new Twisted All-in-One vape
4 - Tilray Brands, Inc. (0001731348) (Issuer)
4 - Tilray Brands, Inc. (0001731348) (Issuer)
4 - Tilray Brands, Inc. (0001731348) (Issuer)
NEW YORK, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (NASDAQ:TLRY, TSX:TLRY), a lifestyle and consumer packaged goods company, announces the launch of "Men's Health on Tap," a new podcast series hosted by distinguished doctors, Dr. John P. Sfakianos, MD, Associate Professor, Department of Urology at the Icahn School of Medicine, and Dr. Steven A. Kaplan, MD, Professor, Department of Urology at the Icahn School of Medicine. The podcast aims to break down stigmas around men's health and invite listeners to an open conversation about important men's health topics. "Men's Health on Tap" is a conversational podcast that covers a wide range of topics, including mental healt
SYDNEY, Australia, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Tilray Medical, a division of Tilray Brands, Inc. ("Tilray Brands") (NASDAQ:TLRY, TSX:TLRY) and a global leader in medical cannabis empowering the therapeutic alliance between patients and healthcare practitioners to make informed individualized health decisions, is pleased to announce the final results of a new scientific study their team has supported titled, "Oral Cannabis Extract for Secondary Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV)." This randomized, placebo-controlled trial aimed to test the effectiveness of an oral cannabis extract in adults suffering from CINV despite standard anti-nausea treatments. Partic
BRECKENRIDGE, Colo., Oct. 31, 2024 (GLOBE NEWSWIRE) -- Breckenridge Brewery, a subsidiary of Tilray Brands, Inc. (NASDAQ:TLRY, TSX:TLRY), today announced an exciting collaboration with the University of Colorado Athletics to bring fans a special edition of its beloved Juice Drop Hazy IPA in a new 19.2 oz. limited-edition can. This exciting partnership celebrates Colorado's rich traditions in both craft beer and collegiate athletics, offering Buffs fans the perfect way to enjoy game day in style. This exciting partnership celebrates Colorado's rich traditions in both craft beer and collegiate athletics, offering Buffs fans the perfect way to enjoy game day in style. The new limited-e